|
 |
|
| Home > Accomplishments |
 |
- KAI was recently selected by a biotech company specializing in development of vaccines focused on bioterrorism threats to be a data management and study operations partner.
- KAI provides drug safety and medical communication services for approximately 90 pharmaceutical products for six clients. The therapeutic areas include: pain management, oncology, cardiovascular disease, infectious disease, endocrine disorders, gastrointestinal disorders, allergic disorders, and psychotropic illnesses.
- The FDA inspected KAI’s pharmacovigilance department in April, 2005 to assure our compliance with 21CFR 314.80. The outcome of the audit was positive and no FDA 483 was issued.
- In August 2007 KAI has been selected to be a CDASH (Clinical Data Acquisition Standards Harmonization Initiative) sub stream member assigned to identify commonly collected Lab data elements. CDASH is a part of the Clinical Data Interchange Standards Consortium (CDISC).
|
|
|
